Trade Summary

2 weeks ago, Ye Weiguo, serving as Chief Operating Officer at GYRE THERAPEUTICS, INC. (GYRE), sold 11,000 shares at $6.25 per share, for a total transaction value of $68,700.00. Following this transaction, Ye Weiguo now holds 700,000 shares of GYRE.

This sale represents a 1.55% decrease in Ye Weiguo's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, June 9, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 22, 2026 at 4:02 PM ET, 13 days after the trade was made.